JPY 2510.0
(-0.08%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 7.6 Billion JPY | 14.14% |
2022 | 6.61 Billion JPY | -14.24% |
2021 | 7.7 Billion JPY | -27.0% |
2020 | 10.56 Billion JPY | 86.08% |
2019 | 5.67 Billion JPY | 46.04% |
2018 | 3.88 Billion JPY | -15.02% |
2017 | 4.57 Billion JPY | -20.09% |
2016 | 5.72 Billion JPY | 22.92% |
2015 | 4.65 Billion JPY | 65.46% |
2014 | 2.81 Billion JPY | -60.81% |
2013 | 7.18 Billion JPY | -12.57% |
2012 | 8.21 Billion JPY | -18.22% |
2011 | 10.04 Billion JPY | 25.51% |
2010 | 8 Billion JPY | 7.93% |
2009 | 7.41 Billion JPY | -4.89% |
2008 | 7.79 Billion JPY | -25.38% |
2007 | 10.44 Billion JPY | 8.89% |
2006 | 9.59 Billion JPY | -13.63% |
2005 | 11.1 Billion JPY | -11.94% |
2004 | 12.6 Billion JPY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 1.59 Billion JPY | 5.22% |
2024 Q2 | 2.5 Billion JPY | 57.06% |
2023 Q2 | 2.63 Billion JPY | 50.4% |
2023 FY | 7.54 Billion JPY | 14.14% |
2023 Q4 | 1.51 Billion JPY | -9.93% |
2023 Q3 | 1.68 Billion JPY | -36.28% |
2023 Q1 | 1.75 Billion JPY | 110.82% |
2022 Q2 | 2.46 Billion JPY | 57.18% |
2022 Q1 | 1.56 Billion JPY | 7.99% |
2022 FY | 6.61 Billion JPY | -14.24% |
2022 Q4 | 832 Million JPY | -52.43% |
2022 Q3 | 1.74 Billion JPY | -28.99% |
2021 Q1 | 1.89 Billion JPY | 3.49% |
2021 FY | 7.7 Billion JPY | -27.0% |
2021 Q4 | 1.45 Billion JPY | -19.39% |
2021 Q2 | 2.56 Billion JPY | 35.13% |
2021 Q3 | 1.8 Billion JPY | -29.74% |
2020 Q3 | 2.18 Billion JPY | -35.7% |
2020 FY | 10.56 Billion JPY | 86.08% |
2020 Q1 | 3.14 Billion JPY | 71.21% |
2020 Q2 | 3.4 Billion JPY | 8.31% |
2020 Q4 | 1.83 Billion JPY | -16.23% |
2019 Q2 | 1.77 Billion JPY | 114.25% |
2019 Q4 | 1.83 Billion JPY | 48.02% |
2019 FY | 5.67 Billion JPY | 46.04% |
2019 Q1 | 828 Million JPY | 93.91% |
2019 Q3 | 1.23 Billion JPY | -30.16% |
2018 Q2 | 1.57 Billion JPY | 66.03% |
2018 Q4 | 427 Million JPY | -54.43% |
2018 FY | 3.88 Billion JPY | -15.02% |
2018 Q1 | 948 Million JPY | 28.28% |
2018 Q3 | 937 Million JPY | -40.47% |
2017 Q3 | 725 Million JPY | -57.18% |
2017 FY | 4.57 Billion JPY | -20.09% |
2017 Q2 | 1.69 Billion JPY | 19.56% |
2017 Q1 | 1.41 Billion JPY | 18.0% |
2017 Q4 | 739 Million JPY | 1.93% |
2016 Q4 | 1.2 Billion JPY | -8.05% |
2016 Q3 | 1.3 Billion JPY | -26.23% |
2016 FY | 5.72 Billion JPY | 22.92% |
2016 Q2 | 1.76 Billion JPY | 22.08% |
2016 Q1 | 1.44 Billion JPY | 0.35% |
2015 Q3 | 950 Million JPY | -28.36% |
2015 Q1 | 936 Million JPY | 447.37% |
2015 Q4 | 1.44 Billion JPY | 52.0% |
2015 FY | 4.65 Billion JPY | 65.46% |
2015 Q2 | 1.32 Billion JPY | 41.67% |
2014 FY | 2.81 Billion JPY | -60.81% |
2014 Q2 | 814 Million JPY | -26.2% |
2014 Q4 | 171 Million JPY | -76.45% |
2014 Q3 | 726 Million JPY | -10.81% |
2014 Q1 | 1.1 Billion JPY | -45.31% |
2013 Q4 | 2.01 Billion JPY | 49.41% |
2013 Q2 | 2.02 Billion JPY | 13.26% |
2013 FY | 7.18 Billion JPY | -12.57% |
2013 Q1 | 1.78 Billion JPY | -17.38% |
2013 Q3 | 1.35 Billion JPY | -33.33% |
2012 FY | 8.21 Billion JPY | -18.22% |
2012 Q3 | 1.58 Billion JPY | -39.67% |
2012 Q2 | 2.63 Billion JPY | 44.33% |
2012 Q4 | 2.16 Billion JPY | 36.19% |
2012 Q1 | 1.82 Billion JPY | -30.48% |
2011 Q2 | 3.12 Billion JPY | 30.07% |
2011 Q1 | 2.4 Billion JPY | 19.51% |
2011 FY | 10.04 Billion JPY | 25.51% |
2011 Q4 | 2.62 Billion JPY | 38.82% |
2011 Q3 | 1.89 Billion JPY | -39.45% |
2010 FY | 8 Billion JPY | 7.93% |
2010 Q2 | 2.72 Billion JPY | 95.0% |
2010 Q4 | 2 Billion JPY | 7.78% |
2010 Q3 | 1.86 Billion JPY | -31.67% |
2010 Q1 | 1.39 Billion JPY | -4.7% |
2009 Q1 | 1.65 Billion JPY | 0.0% |
2009 Q2 | 2.42 Billion JPY | 46.4% |
2009 Q3 | 1.87 Billion JPY | -22.73% |
2009 Q4 | 1.46 Billion JPY | -21.5% |
2009 FY | 7.41 Billion JPY | -4.89% |
2008 FY | 7.79 Billion JPY | -25.38% |
2007 FY | 10.44 Billion JPY | 8.89% |
2006 FY | 9.59 Billion JPY | -13.63% |
2005 FY | 11.1 Billion JPY | -11.94% |
2004 FY | 12.6 Billion JPY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
HEARTSEED INC | -1.45 Billion JPY | 620.754% |
Pharmarise Holdings Corporation | 916 Million JPY | -729.803% |
Qol Holdings Co., Ltd. | 8.32 Billion JPY | 8.697% |
MatsukiyoCocokara & Co. | 75.7 Billion JPY | 89.96% |
Welcia Holdings Co., Ltd. | 43.23 Billion JPY | 82.418% |
Create SD Holdings Co., Ltd. | 20.22 Billion JPY | 62.422% |
NIHON CHOUZAI Co.,Ltd. | 9.14 Billion JPY | 16.874% |
COSMOS Pharmaceutical Corporation | 31.5 Billion JPY | 75.871% |
Tsuruha Holdings Inc. | 49.2 Billion JPY | 84.553% |
Ohki Healthcare Holdings Co.,Ltd. | 2.04 Billion JPY | -271.869% |
Satudora Holdings Co.,Ltd. | 1.38 Billion JPY | -448.809% |
Kusuri No Aoki Holdings Co., Ltd. | 18.56 Billion JPY | 59.066% |
Medical System Network Co., Ltd. | 3.83 Billion JPY | -98.356% |
Shinnihonseiyaku Co., Ltd. | 3.75 Billion JPY | -102.477% |
Sugi Holdings Co.,Ltd. | 36.62 Billion JPY | 79.245% |
YAKUODO HOLDINGS Co., Ltd. | 5.21 Billion JPY | -45.865% |
Astena Holdings Co., Ltd. | 1.12 Billion JPY | -573.792% |
Genky DrugStores Co., Ltd. | 9.01 Billion JPY | 15.694% |
Ain Holdings Inc. | 20.43 Billion JPY | 62.799% |
Sundrug Co.,Ltd. | 40.99 Billion JPY | 81.46% |